Venture Map · Round
53Biologics — Series A · €7M
Announced 2021-09-10 · Valladolid · Biotech
GAEA Inversión and Inveready Biotech III jointly invested €7M, paid in tranches, in Biotechnology Developments for Industry (BDI) to grow its subsidiary 53Biologics into a supplier of enzymes for mRNA production. Inveready Biotech II was already a shareholder. The articles give no stage; Series A is inferred.
RoundSeries A
Amount€7M
LeadNot disclosed
Date2021-09-10
CityValladolid
SectorBiotech
The company
Investors 2
G
GAEA Inversión
IInveready Biotech III
www.inveready.com